Table 3. Association between circulating ANGPTL levels and general medical status (n = 800).

A generalized linear model was used. All variables listed were included in the model. ANGPTL, Angiopoietin-like protein; β, regression coefficient; 95% CI, 95% confidence interval; P, probability; and CKD, chronic kidney disease.

	log(ANGPTL3)			log(ANGPTL4)			log(ANGPTL8)
	β	95%CI	P	β	95%CI	P	β	95%CI	P
Age
>53	0.066	(0.028, 0.104)	0.001	-0.087	(-0.128, -0.046)	<.001	0.051	(0.003, 0.098)	0.038
45–53	0.000	(-0.036, 0.036)	0.984	0.022	(-0.016, 0.061)	0.260	-0.022	(-0.067, 0.023)	0.336
≤44	-	-	-	-	-	-	-	-	-
Male gender	-0.095	(-0.130, -0.059)	<.001	0.148	0.110, 0.186)	<.001	0.050	(0.006, 0.094)	0.027
Smoking	0.004	(-0.032, 0.040)	0.817	0.022	(-0.018, 0.059)	0.298	-0.023	(-0.069, 0.022)	0.306
Drinking	-0.012	(-0.040, 0.017)	0.410	0.002	(-0.028, 0.033)	0.869	-0.032	(-0.069, 0.003)	0.076
Obesity	-0.024	(-0.055, 0.008)	0.140	-0.002	(-0.036, 0.032)	0.915	0.088	(0.049, 0.128)	<.001
Impaired glycometabolism	0.051	(-0.005, 0.106)	0.072	0.101	0.041, 0.160)	<.001	-0.129	(-0.198, -0.059)	<.001
Hypertension	-0.016	(-0.048, 0.017)	0.350	0.000	(-0.035, 0.035)	0.994	0.009	(-0.032, 0.050)	0.653
Dyslipidemia	-0.020	(-0.048, 0.008)	0.162	0.029	(-0.002, 0.059)	0.063	0.085	(0.050, 0.121)	<.001
Hyperuricemia	0.006	(-0.034, 0.046)	0.760	0.018	(-0.025, 0.061)	0.408	0.044	(-0.007, 0.094)	0.090
Hepatic impairment	0.032	(0.001, 0.063)	0.040	0.037	0.004, 0.070)	0.028	0.029	(-0.010, 0.067)	0.146
CKD	0.001	(-0.037, 0.058)	0.672	0.026	(-0.024, 0.077)	0.308	0.029	(-0.031, 0.089)	0.343
Anemia	0.013	(-0.022, 0.048)	0.478	-0.016	(-0.055, 0.022)	0.401	0.004	(-0.040, 0.049)	0.850
Cardiac abnormality	0.034	(-0.081, 0.149)	0.560	-0.084	(-0.207, 0.040)	0.185	0.039	(-0.105, 0.183)	0.596
Inflammation	0.077	(0.018, 0.136)	0.011	-0.110	(-0.173, -0.046)	<.001	-0.025	(-0.099, 0.049)	0.512